J&J Says Its Lung Cancer Drug Combination Keeps People Alive Longer
Johnson & Johnson, a global leader in pharmaceutical innovation, has announced groundbreaking results for its lung cancer drug combination therapy, offering renewed hope to patients battling one of the most aggressive forms of cancer. This latest advancement underscores the company’s…